• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Riley Griffin

Stay informed with Riley Griffin’s coverage and analysis.

In this photo illustration a medical syringe seen displayed
HealthJohnson & Johnson asks FDA for emergency authorization of its single-dose COVID vaccine
By Riley Griffin and BloombergFebruary 4, 2021
F500-2020-069-Merck
HealthMerck ends development of two COVID-19 vaccines after weak trial results
By Bloomberg and Riley GriffinJanuary 25, 2021
J&J says efficacy of one-shot COVID-19 vaccine could beat expectations
HealthJ&J says efficacy of one-shot COVID-19 vaccine could beat expectations
By Riley Griffin and BloombergJanuary 13, 2021
Pfizer to supply U.S. with 100 million more vaccine doses
HealthPfizer to supply U.S. with 100 million more vaccine doses
By John Lauerman, Riley Griffin and BloombergDecember 23, 2020
ITALY-HEALTH-VIRUS-SCIENCE-TECHNOLOGY-PHARMACEUTICALS-VACCINE-MA
HealthU.S. plan to vaccinate most Americans by summer depends on AstraZeneca and J&J
By Riley Griffin and BloombergDecember 8, 2020
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
HealthEli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By Riley Griffin and BloombergNovember 10, 2020
Prime Minister Scott Morrison Announces Two New COVID-19 Vaccine Supply Agreements
Germany funded the development of Pfizer’s COVID vaccine—not U.S.’s Operation Warp Speed
By Riley Griffin, Drew Armstrong and BloombergNovember 9, 2020
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
HealthPfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By Robert Langreth, Naomi Kresge, Riley Griffin and BloombergNovember 9, 2020
ARGENTINA-HEALTH-VIRUS-VACCINE-LABORATORY
Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt
By Michelle Fay Cortez, Riley Griffin and BloombergSeptember 8, 2020
Senate HELP Committee Holds Hearing On Safely Going Back To Work And School During Pandemic
HealthAnthony Fauci says coronavirus vaccine immunity is likely to be ‘finite’
By Riley Griffin and BloombergJuly 7, 2020
Dr. Fauci’s worst nightmare? We’re living it
HealthDr. Fauci’s worst nightmare? We’re living it
By John Lauerman, Riley Griffin and BloombergJune 10, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
FinanceFrance’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
Former Turing Pharmaceuticals CEO Martin Shkreli Jury To Start Deliberations In Fraud Trial
Health‘Pharma bro’ Martin Shkreli sued for alleged violation of antitrust law
By Erik Larson, Riley Griffin and BloombergJanuary 27, 2020
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
HealthCancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By Riley Griffin, James Paton and BloombergDecember 9, 2019
Purdue Pharma bankruptcy
HealthSackler Family Backs $11B Settlement of Opioid Lawsuits That Would See Purdue Pharma File for Bankruptcy
By Jef Feeley, Riley Griffin and BloombergAugust 28, 2019
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Economy
'We didn’t see this coming': Wall Street eats its forecasts as stocks sell off globally on fear of AI bubble ahead of SpaceX IPOplaceholder alt text
By Jim EdwardsJune 8, 2026
Success
Gen Zers are arriving at college unable to even read a sentence—professors warn it could lead to a generation of anxious and lonely graduatesplaceholder alt text
By Preston ForeJune 7, 2026
Environment
Trump, who has repeatedly called climate change fake, is now threatening Brazil with tariffs over the deforestation of the Amazonplaceholder alt text
By Sasha RogelbergJune 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.